Global Puerarin for Injection Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Puerarin for Injection is a pharmaceutical product derived from the root of the kudzu plant (Pueraria lobata), traditionally used in Chinese medicine. Puerarin contains bioactive compounds such as isoflavones, particularly puerarin, known for its antioxidant, vasodilatory, and neuroprotective properties. This injectable form of puerarin is used in the treatment of cardiovascular diseases, including coronary artery disease, hypertension, and angina pectoris. It improves blood flow, reduces oxidative stress, and enhances cardiac function, making it beneficial for patients with cardiovascular conditions. Puerarin injections are administered in hospitals and clinics as an adjunct therapy for managing cardiovascular risk factors and preventing cardiovascular events.
The global Puerarin for Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Puerarin for Injection Industry Forecast” looks at past sales and reviews total world Puerarin for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Puerarin for Injection sales for 2024 through 2030. With Puerarin for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Puerarin for Injection industry.
This Insight Report provides a comprehensive analysis of the global Puerarin for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Puerarin for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Puerarin for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Puerarin for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Puerarin for Injection.
The industry trend for Puerarin for Injection reflects a growing interest in natural remedies and botanical medicines for cardiovascular health and disease prevention. With a shift towards holistic approaches to healthcare, there's increasing demand for plant-derived therapeutics like puerarin that offer cardiovascular benefits with potentially fewer side effects compared to conventional medications. Pharmaceutical companies are investing in research and development to explore the pharmacological properties and therapeutic applications of puerarin and its derivatives in cardiovascular medicine. Additionally, there's a focus on developing standardized formulations and quality control measures to ensure the safety, efficacy, and reproducibility of puerarin injections, driving their integration into evidence-based treatment protocols for cardiovascular diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Puerarin for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Puerarin for Injection market?
What factors are driving Puerarin for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Puerarin for Injection market opportunities vary by end market size?
How does Puerarin for Injection break out by Type, by Application?
Puerarin for Injection is a pharmaceutical product derived from the root of the kudzu plant (Pueraria lobata), traditionally used in Chinese medicine. Puerarin contains bioactive compounds such as isoflavones, particularly puerarin, known for its antioxidant, vasodilatory, and neuroprotective properties. This injectable form of puerarin is used in the treatment of cardiovascular diseases, including coronary artery disease, hypertension, and angina pectoris. It improves blood flow, reduces oxidative stress, and enhances cardiac function, making it beneficial for patients with cardiovascular conditions. Puerarin injections are administered in hospitals and clinics as an adjunct therapy for managing cardiovascular risk factors and preventing cardiovascular events.
The global Puerarin for Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Puerarin for Injection Industry Forecast” looks at past sales and reviews total world Puerarin for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Puerarin for Injection sales for 2024 through 2030. With Puerarin for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Puerarin for Injection industry.
This Insight Report provides a comprehensive analysis of the global Puerarin for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Puerarin for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Puerarin for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Puerarin for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Puerarin for Injection.
The industry trend for Puerarin for Injection reflects a growing interest in natural remedies and botanical medicines for cardiovascular health and disease prevention. With a shift towards holistic approaches to healthcare, there's increasing demand for plant-derived therapeutics like puerarin that offer cardiovascular benefits with potentially fewer side effects compared to conventional medications. Pharmaceutical companies are investing in research and development to explore the pharmacological properties and therapeutic applications of puerarin and its derivatives in cardiovascular medicine. Additionally, there's a focus on developing standardized formulations and quality control measures to ensure the safety, efficacy, and reproducibility of puerarin injections, driving their integration into evidence-based treatment protocols for cardiovascular diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Puerarin for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 0.1g
- 0.2g
- Others
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Procurenet
- Actiza Pharmaceutical
- Chengdu Tiantai Mountain Pharmaceutical
- You Care
- Harbin Sanlian Pharmaceutical
- Beijing Sihuan Kebao Pharmaceutical
- Hubei Tianyao Pharmaceutical
What is the 10-year outlook for the global Puerarin for Injection market?
What factors are driving Puerarin for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Puerarin for Injection market opportunities vary by end market size?
How does Puerarin for Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Puerarin for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Puerarin for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Puerarin for Injection by Country/Region, 2019, 2023 & 2030
2.2 Puerarin for Injection Segment by Type
2.2.1 0.1g
2.2.2 0.2g
2.2.3 Others
2.3 Puerarin for Injection Sales by Type
2.3.1 Global Puerarin for Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Puerarin for Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Puerarin for Injection Sale Price by Type (2019-2024)
2.4 Puerarin for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Puerarin for Injection Sales by Application
2.5.1 Global Puerarin for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Puerarin for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Puerarin for Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Puerarin for Injection Breakdown Data by Company
3.1.1 Global Puerarin for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Puerarin for Injection Sales Market Share by Company (2019-2024)
3.2 Global Puerarin for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Puerarin for Injection Revenue by Company (2019-2024)
3.2.2 Global Puerarin for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Puerarin for Injection Sale Price by Company
3.4 Key Manufacturers Puerarin for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Puerarin for Injection Product Location Distribution
3.4.2 Players Puerarin for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PUERARIN FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Puerarin for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Puerarin for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Puerarin for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Puerarin for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Puerarin for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Puerarin for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Puerarin for Injection Sales Growth
4.4 APAC Puerarin for Injection Sales Growth
4.5 Europe Puerarin for Injection Sales Growth
4.6 Middle East & Africa Puerarin for Injection Sales Growth
5 AMERICAS
5.1 Americas Puerarin for Injection Sales by Country
5.1.1 Americas Puerarin for Injection Sales by Country (2019-2024)
5.1.2 Americas Puerarin for Injection Revenue by Country (2019-2024)
5.2 Americas Puerarin for Injection Sales by Type (2019-2024)
5.3 Americas Puerarin for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Puerarin for Injection Sales by Region
6.1.1 APAC Puerarin for Injection Sales by Region (2019-2024)
6.1.2 APAC Puerarin for Injection Revenue by Region (2019-2024)
6.2 APAC Puerarin for Injection Sales by Type (2019-2024)
6.3 APAC Puerarin for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Puerarin for Injection by Country
7.1.1 Europe Puerarin for Injection Sales by Country (2019-2024)
7.1.2 Europe Puerarin for Injection Revenue by Country (2019-2024)
7.2 Europe Puerarin for Injection Sales by Type (2019-2024)
7.3 Europe Puerarin for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Puerarin for Injection by Country
8.1.1 Middle East & Africa Puerarin for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Puerarin for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Puerarin for Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Puerarin for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Puerarin for Injection
10.3 Manufacturing Process Analysis of Puerarin for Injection
10.4 Industry Chain Structure of Puerarin for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Puerarin for Injection Distributors
11.3 Puerarin for Injection Customer
12 WORLD FORECAST REVIEW FOR PUERARIN FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Puerarin for Injection Market Size Forecast by Region
12.1.1 Global Puerarin for Injection Forecast by Region (2025-2030)
12.1.2 Global Puerarin for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Puerarin for Injection Forecast by Type (2025-2030)
12.7 Global Puerarin for Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Procurenet
13.1.1 Procurenet Company Information
13.1.2 Procurenet Puerarin for Injection Product Portfolios and Specifications
13.1.3 Procurenet Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Procurenet Main Business Overview
13.1.5 Procurenet Latest Developments
13.2 Actiza Pharmaceutical
13.2.1 Actiza Pharmaceutical Company Information
13.2.2 Actiza Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.2.3 Actiza Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Actiza Pharmaceutical Main Business Overview
13.2.5 Actiza Pharmaceutical Latest Developments
13.3 Chengdu Tiantai Mountain Pharmaceutical
13.3.1 Chengdu Tiantai Mountain Pharmaceutical Company Information
13.3.2 Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.3.3 Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Chengdu Tiantai Mountain Pharmaceutical Main Business Overview
13.3.5 Chengdu Tiantai Mountain Pharmaceutical Latest Developments
13.4 You Care
13.4.1 You Care Company Information
13.4.2 You Care Puerarin for Injection Product Portfolios and Specifications
13.4.3 You Care Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 You Care Main Business Overview
13.4.5 You Care Latest Developments
13.5 Harbin Sanlian Pharmaceutical
13.5.1 Harbin Sanlian Pharmaceutical Company Information
13.5.2 Harbin Sanlian Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.5.3 Harbin Sanlian Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Harbin Sanlian Pharmaceutical Main Business Overview
13.5.5 Harbin Sanlian Pharmaceutical Latest Developments
13.6 Beijing Sihuan Kebao Pharmaceutical
13.6.1 Beijing Sihuan Kebao Pharmaceutical Company Information
13.6.2 Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.6.3 Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Beijing Sihuan Kebao Pharmaceutical Main Business Overview
13.6.5 Beijing Sihuan Kebao Pharmaceutical Latest Developments
13.7 Hubei Tianyao Pharmaceutical
13.7.1 Hubei Tianyao Pharmaceutical Company Information
13.7.2 Hubei Tianyao Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.7.3 Hubei Tianyao Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hubei Tianyao Pharmaceutical Main Business Overview
13.7.5 Hubei Tianyao Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Puerarin for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Puerarin for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Puerarin for Injection by Country/Region, 2019, 2023 & 2030
2.2 Puerarin for Injection Segment by Type
2.2.1 0.1g
2.2.2 0.2g
2.2.3 Others
2.3 Puerarin for Injection Sales by Type
2.3.1 Global Puerarin for Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Puerarin for Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Puerarin for Injection Sale Price by Type (2019-2024)
2.4 Puerarin for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Puerarin for Injection Sales by Application
2.5.1 Global Puerarin for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Puerarin for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Puerarin for Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Puerarin for Injection Breakdown Data by Company
3.1.1 Global Puerarin for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Puerarin for Injection Sales Market Share by Company (2019-2024)
3.2 Global Puerarin for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Puerarin for Injection Revenue by Company (2019-2024)
3.2.2 Global Puerarin for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Puerarin for Injection Sale Price by Company
3.4 Key Manufacturers Puerarin for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Puerarin for Injection Product Location Distribution
3.4.2 Players Puerarin for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PUERARIN FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Puerarin for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Puerarin for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Puerarin for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Puerarin for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Puerarin for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Puerarin for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Puerarin for Injection Sales Growth
4.4 APAC Puerarin for Injection Sales Growth
4.5 Europe Puerarin for Injection Sales Growth
4.6 Middle East & Africa Puerarin for Injection Sales Growth
5 AMERICAS
5.1 Americas Puerarin for Injection Sales by Country
5.1.1 Americas Puerarin for Injection Sales by Country (2019-2024)
5.1.2 Americas Puerarin for Injection Revenue by Country (2019-2024)
5.2 Americas Puerarin for Injection Sales by Type (2019-2024)
5.3 Americas Puerarin for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Puerarin for Injection Sales by Region
6.1.1 APAC Puerarin for Injection Sales by Region (2019-2024)
6.1.2 APAC Puerarin for Injection Revenue by Region (2019-2024)
6.2 APAC Puerarin for Injection Sales by Type (2019-2024)
6.3 APAC Puerarin for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Puerarin for Injection by Country
7.1.1 Europe Puerarin for Injection Sales by Country (2019-2024)
7.1.2 Europe Puerarin for Injection Revenue by Country (2019-2024)
7.2 Europe Puerarin for Injection Sales by Type (2019-2024)
7.3 Europe Puerarin for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Puerarin for Injection by Country
8.1.1 Middle East & Africa Puerarin for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Puerarin for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Puerarin for Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Puerarin for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Puerarin for Injection
10.3 Manufacturing Process Analysis of Puerarin for Injection
10.4 Industry Chain Structure of Puerarin for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Puerarin for Injection Distributors
11.3 Puerarin for Injection Customer
12 WORLD FORECAST REVIEW FOR PUERARIN FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Puerarin for Injection Market Size Forecast by Region
12.1.1 Global Puerarin for Injection Forecast by Region (2025-2030)
12.1.2 Global Puerarin for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Puerarin for Injection Forecast by Type (2025-2030)
12.7 Global Puerarin for Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Procurenet
13.1.1 Procurenet Company Information
13.1.2 Procurenet Puerarin for Injection Product Portfolios and Specifications
13.1.3 Procurenet Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Procurenet Main Business Overview
13.1.5 Procurenet Latest Developments
13.2 Actiza Pharmaceutical
13.2.1 Actiza Pharmaceutical Company Information
13.2.2 Actiza Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.2.3 Actiza Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Actiza Pharmaceutical Main Business Overview
13.2.5 Actiza Pharmaceutical Latest Developments
13.3 Chengdu Tiantai Mountain Pharmaceutical
13.3.1 Chengdu Tiantai Mountain Pharmaceutical Company Information
13.3.2 Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.3.3 Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Chengdu Tiantai Mountain Pharmaceutical Main Business Overview
13.3.5 Chengdu Tiantai Mountain Pharmaceutical Latest Developments
13.4 You Care
13.4.1 You Care Company Information
13.4.2 You Care Puerarin for Injection Product Portfolios and Specifications
13.4.3 You Care Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 You Care Main Business Overview
13.4.5 You Care Latest Developments
13.5 Harbin Sanlian Pharmaceutical
13.5.1 Harbin Sanlian Pharmaceutical Company Information
13.5.2 Harbin Sanlian Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.5.3 Harbin Sanlian Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Harbin Sanlian Pharmaceutical Main Business Overview
13.5.5 Harbin Sanlian Pharmaceutical Latest Developments
13.6 Beijing Sihuan Kebao Pharmaceutical
13.6.1 Beijing Sihuan Kebao Pharmaceutical Company Information
13.6.2 Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.6.3 Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Beijing Sihuan Kebao Pharmaceutical Main Business Overview
13.6.5 Beijing Sihuan Kebao Pharmaceutical Latest Developments
13.7 Hubei Tianyao Pharmaceutical
13.7.1 Hubei Tianyao Pharmaceutical Company Information
13.7.2 Hubei Tianyao Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
13.7.3 Hubei Tianyao Pharmaceutical Puerarin for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hubei Tianyao Pharmaceutical Main Business Overview
13.7.5 Hubei Tianyao Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Puerarin for Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Puerarin for Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 0.1g
Table 4. Major Players of 0.2g
Table 5. Major Players of Others
Table 6. Global Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 7. Global Puerarin for Injection Sales Market Share by Type (2019-2024)
Table 8. Global Puerarin for Injection Revenue by Type (2019-2024) & ($ million)
Table 9. Global Puerarin for Injection Revenue Market Share by Type (2019-2024)
Table 10. Global Puerarin for Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Puerarin for Injection Sale by Application (2019-2024) & (Units)
Table 12. Global Puerarin for Injection Sale Market Share by Application (2019-2024)
Table 13. Global Puerarin for Injection Revenue by Application (2019-2024) & ($ million)
Table 14. Global Puerarin for Injection Revenue Market Share by Application (2019-2024)
Table 15. Global Puerarin for Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Puerarin for Injection Sales by Company (2019-2024) & (Units)
Table 17. Global Puerarin for Injection Sales Market Share by Company (2019-2024)
Table 18. Global Puerarin for Injection Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Puerarin for Injection Revenue Market Share by Company (2019-2024)
Table 20. Global Puerarin for Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Puerarin for Injection Producing Area Distribution and Sales Area
Table 22. Players Puerarin for Injection Products Offered
Table 23. Puerarin for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Puerarin for Injection Sales by Geographic Region (2019-2024) & (Units)
Table 27. Global Puerarin for Injection Sales Market Share Geographic Region (2019-2024)
Table 28. Global Puerarin for Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Puerarin for Injection Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Puerarin for Injection Sales by Country/Region (2019-2024) & (Units)
Table 31. Global Puerarin for Injection Sales Market Share by Country/Region (2019-2024)
Table 32. Global Puerarin for Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Puerarin for Injection Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 35. Americas Puerarin for Injection Sales Market Share by Country (2019-2024)
Table 36. Americas Puerarin for Injection Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 38. Americas Puerarin for Injection Sales by Application (2019-2024) & (Units)
Table 39. APAC Puerarin for Injection Sales by Region (2019-2024) & (Units)
Table 40. APAC Puerarin for Injection Sales Market Share by Region (2019-2024)
Table 41. APAC Puerarin for Injection Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 43. APAC Puerarin for Injection Sales by Application (2019-2024) & (Units)
Table 44. Europe Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 45. Europe Puerarin for Injection Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 47. Europe Puerarin for Injection Sales by Application (2019-2024) & (Units)
Table 48. Middle East & Africa Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 49. Middle East & Africa Puerarin for Injection Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 51. Middle East & Africa Puerarin for Injection Sales by Application (2019-2024) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Puerarin for Injection
Table 53. Key Market Challenges & Risks of Puerarin for Injection
Table 54. Key Industry Trends of Puerarin for Injection
Table 55. Puerarin for Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Puerarin for Injection Distributors List
Table 58. Puerarin for Injection Customer List
Table 59. Global Puerarin for Injection Sales Forecast by Region (2025-2030) & (Units)
Table 60. Global Puerarin for Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Puerarin for Injection Sales Forecast by Country (2025-2030) & (Units)
Table 62. Americas Puerarin for Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Puerarin for Injection Sales Forecast by Region (2025-2030) & (Units)
Table 64. APAC Puerarin for Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Puerarin for Injection Sales Forecast by Country (2025-2030) & (Units)
Table 66. Europe Puerarin for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Puerarin for Injection Sales Forecast by Country (2025-2030) & (Units)
Table 68. Middle East & Africa Puerarin for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Puerarin for Injection Sales Forecast by Type (2025-2030) & (Units)
Table 70. Global Puerarin for Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Puerarin for Injection Sales Forecast by Application (2025-2030) & (Units)
Table 72. Global Puerarin for Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Procurenet Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Procurenet Puerarin for Injection Product Portfolios and Specifications
Table 75. Procurenet Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Procurenet Main Business
Table 77. Procurenet Latest Developments
Table 78. Actiza Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Actiza Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 80. Actiza Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Actiza Pharmaceutical Main Business
Table 82. Actiza Pharmaceutical Latest Developments
Table 83. Chengdu Tiantai Mountain Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 85. Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Chengdu Tiantai Mountain Pharmaceutical Main Business
Table 87. Chengdu Tiantai Mountain Pharmaceutical Latest Developments
Table 88. You Care Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. You Care Puerarin for Injection Product Portfolios and Specifications
Table 90. You Care Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. You Care Main Business
Table 92. You Care Latest Developments
Table 93. Harbin Sanlian Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Harbin Sanlian Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 95. Harbin Sanlian Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Harbin Sanlian Pharmaceutical Main Business
Table 97. Harbin Sanlian Pharmaceutical Latest Developments
Table 98. Beijing Sihuan Kebao Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 100. Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Beijing Sihuan Kebao Pharmaceutical Main Business
Table 102. Beijing Sihuan Kebao Pharmaceutical Latest Developments
Table 103. Hubei Tianyao Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Hubei Tianyao Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 105. Hubei Tianyao Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Hubei Tianyao Pharmaceutical Main Business
Table 107. Hubei Tianyao Pharmaceutical Latest Developments
Table 1. Puerarin for Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Puerarin for Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 0.1g
Table 4. Major Players of 0.2g
Table 5. Major Players of Others
Table 6. Global Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 7. Global Puerarin for Injection Sales Market Share by Type (2019-2024)
Table 8. Global Puerarin for Injection Revenue by Type (2019-2024) & ($ million)
Table 9. Global Puerarin for Injection Revenue Market Share by Type (2019-2024)
Table 10. Global Puerarin for Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Puerarin for Injection Sale by Application (2019-2024) & (Units)
Table 12. Global Puerarin for Injection Sale Market Share by Application (2019-2024)
Table 13. Global Puerarin for Injection Revenue by Application (2019-2024) & ($ million)
Table 14. Global Puerarin for Injection Revenue Market Share by Application (2019-2024)
Table 15. Global Puerarin for Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Puerarin for Injection Sales by Company (2019-2024) & (Units)
Table 17. Global Puerarin for Injection Sales Market Share by Company (2019-2024)
Table 18. Global Puerarin for Injection Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Puerarin for Injection Revenue Market Share by Company (2019-2024)
Table 20. Global Puerarin for Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Puerarin for Injection Producing Area Distribution and Sales Area
Table 22. Players Puerarin for Injection Products Offered
Table 23. Puerarin for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Puerarin for Injection Sales by Geographic Region (2019-2024) & (Units)
Table 27. Global Puerarin for Injection Sales Market Share Geographic Region (2019-2024)
Table 28. Global Puerarin for Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Puerarin for Injection Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Puerarin for Injection Sales by Country/Region (2019-2024) & (Units)
Table 31. Global Puerarin for Injection Sales Market Share by Country/Region (2019-2024)
Table 32. Global Puerarin for Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Puerarin for Injection Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 35. Americas Puerarin for Injection Sales Market Share by Country (2019-2024)
Table 36. Americas Puerarin for Injection Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 38. Americas Puerarin for Injection Sales by Application (2019-2024) & (Units)
Table 39. APAC Puerarin for Injection Sales by Region (2019-2024) & (Units)
Table 40. APAC Puerarin for Injection Sales Market Share by Region (2019-2024)
Table 41. APAC Puerarin for Injection Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 43. APAC Puerarin for Injection Sales by Application (2019-2024) & (Units)
Table 44. Europe Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 45. Europe Puerarin for Injection Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 47. Europe Puerarin for Injection Sales by Application (2019-2024) & (Units)
Table 48. Middle East & Africa Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 49. Middle East & Africa Puerarin for Injection Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Puerarin for Injection Sales by Type (2019-2024) & (Units)
Table 51. Middle East & Africa Puerarin for Injection Sales by Application (2019-2024) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Puerarin for Injection
Table 53. Key Market Challenges & Risks of Puerarin for Injection
Table 54. Key Industry Trends of Puerarin for Injection
Table 55. Puerarin for Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Puerarin for Injection Distributors List
Table 58. Puerarin for Injection Customer List
Table 59. Global Puerarin for Injection Sales Forecast by Region (2025-2030) & (Units)
Table 60. Global Puerarin for Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Puerarin for Injection Sales Forecast by Country (2025-2030) & (Units)
Table 62. Americas Puerarin for Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Puerarin for Injection Sales Forecast by Region (2025-2030) & (Units)
Table 64. APAC Puerarin for Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Puerarin for Injection Sales Forecast by Country (2025-2030) & (Units)
Table 66. Europe Puerarin for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Puerarin for Injection Sales Forecast by Country (2025-2030) & (Units)
Table 68. Middle East & Africa Puerarin for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Puerarin for Injection Sales Forecast by Type (2025-2030) & (Units)
Table 70. Global Puerarin for Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Puerarin for Injection Sales Forecast by Application (2025-2030) & (Units)
Table 72. Global Puerarin for Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Procurenet Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Procurenet Puerarin for Injection Product Portfolios and Specifications
Table 75. Procurenet Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Procurenet Main Business
Table 77. Procurenet Latest Developments
Table 78. Actiza Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Actiza Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 80. Actiza Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Actiza Pharmaceutical Main Business
Table 82. Actiza Pharmaceutical Latest Developments
Table 83. Chengdu Tiantai Mountain Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 85. Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Chengdu Tiantai Mountain Pharmaceutical Main Business
Table 87. Chengdu Tiantai Mountain Pharmaceutical Latest Developments
Table 88. You Care Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. You Care Puerarin for Injection Product Portfolios and Specifications
Table 90. You Care Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. You Care Main Business
Table 92. You Care Latest Developments
Table 93. Harbin Sanlian Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Harbin Sanlian Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 95. Harbin Sanlian Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Harbin Sanlian Pharmaceutical Main Business
Table 97. Harbin Sanlian Pharmaceutical Latest Developments
Table 98. Beijing Sihuan Kebao Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 100. Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Beijing Sihuan Kebao Pharmaceutical Main Business
Table 102. Beijing Sihuan Kebao Pharmaceutical Latest Developments
Table 103. Hubei Tianyao Pharmaceutical Basic Information, Puerarin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Hubei Tianyao Pharmaceutical Puerarin for Injection Product Portfolios and Specifications
Table 105. Hubei Tianyao Pharmaceutical Puerarin for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Hubei Tianyao Pharmaceutical Main Business
Table 107. Hubei Tianyao Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Puerarin for Injection
Figure 2. Puerarin for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Puerarin for Injection Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Puerarin for Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Puerarin for Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Puerarin for Injection Sales Market Share by Country/Region (2023)
Figure 10. Puerarin for Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 0.1g
Figure 12. Product Picture of 0.2g
Figure 13. Product Picture of Others
Figure 14. Global Puerarin for Injection Sales Market Share by Type in 2023
Figure 15. Global Puerarin for Injection Revenue Market Share by Type (2019-2024)
Figure 16. Puerarin for Injection Consumed in Hospital
Figure 17. Global Puerarin for Injection Market: Hospital (2019-2024) & (Units)
Figure 18. Puerarin for Injection Consumed in Clinic
Figure 19. Global Puerarin for Injection Market: Clinic (2019-2024) & (Units)
Figure 20. Global Puerarin for Injection Sale Market Share by Application (2023)
Figure 21. Global Puerarin for Injection Revenue Market Share by Application in 2023
Figure 22. Puerarin for Injection Sales by Company in 2023 (Units)
Figure 23. Global Puerarin for Injection Sales Market Share by Company in 2023
Figure 24. Puerarin for Injection Revenue by Company in 2023 ($ millions)
Figure 25. Global Puerarin for Injection Revenue Market Share by Company in 2023
Figure 26. Global Puerarin for Injection Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Puerarin for Injection Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Puerarin for Injection Sales 2019-2024 (Units)
Figure 29. Americas Puerarin for Injection Revenue 2019-2024 ($ millions)
Figure 30. APAC Puerarin for Injection Sales 2019-2024 (Units)
Figure 31. APAC Puerarin for Injection Revenue 2019-2024 ($ millions)
Figure 32. Europe Puerarin for Injection Sales 2019-2024 (Units)
Figure 33. Europe Puerarin for Injection Revenue 2019-2024 ($ millions)
Figure 34. Middle East & Africa Puerarin for Injection Sales 2019-2024 (Units)
Figure 35. Middle East & Africa Puerarin for Injection Revenue 2019-2024 ($ millions)
Figure 36. Americas Puerarin for Injection Sales Market Share by Country in 2023
Figure 37. Americas Puerarin for Injection Revenue Market Share by Country (2019-2024)
Figure 38. Americas Puerarin for Injection Sales Market Share by Type (2019-2024)
Figure 39. Americas Puerarin for Injection Sales Market Share by Application (2019-2024)
Figure 40. United States Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 41. Canada Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 42. Mexico Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. Brazil Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. APAC Puerarin for Injection Sales Market Share by Region in 2023
Figure 45. APAC Puerarin for Injection Revenue Market Share by Region (2019-2024)
Figure 46. APAC Puerarin for Injection Sales Market Share by Type (2019-2024)
Figure 47. APAC Puerarin for Injection Sales Market Share by Application (2019-2024)
Figure 48. China Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 49. Japan Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 50. South Korea Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. Southeast Asia Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. India Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. Australia Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. China Taiwan Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. Europe Puerarin for Injection Sales Market Share by Country in 2023
Figure 56. Europe Puerarin for Injection Revenue Market Share by Country (2019-2024)
Figure 57. Europe Puerarin for Injection Sales Market Share by Type (2019-2024)
Figure 58. Europe Puerarin for Injection Sales Market Share by Application (2019-2024)
Figure 59. Germany Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 60. France Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 61. UK Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. Italy Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. Russia Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. Middle East & Africa Puerarin for Injection Sales Market Share by Country (2019-2024)
Figure 65. Middle East & Africa Puerarin for Injection Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Puerarin for Injection Sales Market Share by Application (2019-2024)
Figure 67. Egypt Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 68. South Africa Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. Israel Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. Turkey Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. GCC Countries Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Puerarin for Injection in 2023
Figure 73. Manufacturing Process Analysis of Puerarin for Injection
Figure 74. Industry Chain Structure of Puerarin for Injection
Figure 75. Channels of Distribution
Figure 76. Global Puerarin for Injection Sales Market Forecast by Region (2025-2030)
Figure 77. Global Puerarin for Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Puerarin for Injection Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Puerarin for Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Puerarin for Injection Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Puerarin for Injection Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Puerarin for Injection
Figure 2. Puerarin for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Puerarin for Injection Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Puerarin for Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Puerarin for Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Puerarin for Injection Sales Market Share by Country/Region (2023)
Figure 10. Puerarin for Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 0.1g
Figure 12. Product Picture of 0.2g
Figure 13. Product Picture of Others
Figure 14. Global Puerarin for Injection Sales Market Share by Type in 2023
Figure 15. Global Puerarin for Injection Revenue Market Share by Type (2019-2024)
Figure 16. Puerarin for Injection Consumed in Hospital
Figure 17. Global Puerarin for Injection Market: Hospital (2019-2024) & (Units)
Figure 18. Puerarin for Injection Consumed in Clinic
Figure 19. Global Puerarin for Injection Market: Clinic (2019-2024) & (Units)
Figure 20. Global Puerarin for Injection Sale Market Share by Application (2023)
Figure 21. Global Puerarin for Injection Revenue Market Share by Application in 2023
Figure 22. Puerarin for Injection Sales by Company in 2023 (Units)
Figure 23. Global Puerarin for Injection Sales Market Share by Company in 2023
Figure 24. Puerarin for Injection Revenue by Company in 2023 ($ millions)
Figure 25. Global Puerarin for Injection Revenue Market Share by Company in 2023
Figure 26. Global Puerarin for Injection Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Puerarin for Injection Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Puerarin for Injection Sales 2019-2024 (Units)
Figure 29. Americas Puerarin for Injection Revenue 2019-2024 ($ millions)
Figure 30. APAC Puerarin for Injection Sales 2019-2024 (Units)
Figure 31. APAC Puerarin for Injection Revenue 2019-2024 ($ millions)
Figure 32. Europe Puerarin for Injection Sales 2019-2024 (Units)
Figure 33. Europe Puerarin for Injection Revenue 2019-2024 ($ millions)
Figure 34. Middle East & Africa Puerarin for Injection Sales 2019-2024 (Units)
Figure 35. Middle East & Africa Puerarin for Injection Revenue 2019-2024 ($ millions)
Figure 36. Americas Puerarin for Injection Sales Market Share by Country in 2023
Figure 37. Americas Puerarin for Injection Revenue Market Share by Country (2019-2024)
Figure 38. Americas Puerarin for Injection Sales Market Share by Type (2019-2024)
Figure 39. Americas Puerarin for Injection Sales Market Share by Application (2019-2024)
Figure 40. United States Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 41. Canada Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 42. Mexico Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. Brazil Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. APAC Puerarin for Injection Sales Market Share by Region in 2023
Figure 45. APAC Puerarin for Injection Revenue Market Share by Region (2019-2024)
Figure 46. APAC Puerarin for Injection Sales Market Share by Type (2019-2024)
Figure 47. APAC Puerarin for Injection Sales Market Share by Application (2019-2024)
Figure 48. China Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 49. Japan Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 50. South Korea Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. Southeast Asia Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. India Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. Australia Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. China Taiwan Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. Europe Puerarin for Injection Sales Market Share by Country in 2023
Figure 56. Europe Puerarin for Injection Revenue Market Share by Country (2019-2024)
Figure 57. Europe Puerarin for Injection Sales Market Share by Type (2019-2024)
Figure 58. Europe Puerarin for Injection Sales Market Share by Application (2019-2024)
Figure 59. Germany Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 60. France Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 61. UK Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. Italy Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. Russia Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. Middle East & Africa Puerarin for Injection Sales Market Share by Country (2019-2024)
Figure 65. Middle East & Africa Puerarin for Injection Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Puerarin for Injection Sales Market Share by Application (2019-2024)
Figure 67. Egypt Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 68. South Africa Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. Israel Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. Turkey Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. GCC Countries Puerarin for Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Puerarin for Injection in 2023
Figure 73. Manufacturing Process Analysis of Puerarin for Injection
Figure 74. Industry Chain Structure of Puerarin for Injection
Figure 75. Channels of Distribution
Figure 76. Global Puerarin for Injection Sales Market Forecast by Region (2025-2030)
Figure 77. Global Puerarin for Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Puerarin for Injection Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Puerarin for Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Puerarin for Injection Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Puerarin for Injection Revenue Market Share Forecast by Application (2025-2030)
